产品活性： PF-07104091 hydrate 是一种高效选择性的 CDK2/cyclin E1 和 GSK3β 抑制剂，其 Ki 分别为 1.16 和 537.81 nM。PF-07104091 hydrate ...

The gut microbiome, or the community of microorganisms residing in the gastrointestinal tract, has emerged as an important ...

The Bruton tyrosine kinase inhibitor was approved in combination with bendamustine and rituximab in previously untreated ...

Acalabrutinib with bendamustine and rituximab is now an FDA-approved treatment for patients with previously untreated mantle ...

Gut microbiota-derived phenylacetylglutamine accelerates aging by driving cellular senescence through mitochondrial ...

The FDA approved acalabrutinib in combination with bendamustine and rituximab for adults with previously untreated mantle ...

As cancer treatment costs have increased, identifying and treating early-stage cancer sooner reduces expenses and improves ...

SCIENCE CHINA Life Sciences近日以开放获取（OA）形式在线发表发表国家生物医学分析中心南湖实验室的满江红研究员、李爱玲研究员，与中国人民解放军总医院第一医学中心神经外科李昉晔教授题为“FSD1 inhibits ...

Analysts at StockNews.com initiated coverage on shares of Syros Pharmaceuticals (NASDAQ:SYRS – Get Free Report) in a research ...

CT表现 腹腔内靠近脊柱左前方腹膜后区域见不规则团片状稍低密度影，范围约 26 × 28 mm，边界尚清，病灶内部区域密度大致均匀，偏后方区域脂肪间隙模糊（冠状位蓝色箭头） 增强检查病灶动脉期明确不均匀性强化，内见小片状、裂隙状稍低密度影 ...